Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors.

Nayak-Kapoor A, Hao Z, Sadek R, Dobbins R, Marshall L, Vahanian NN, Jay Ramsey W, Kennedy E, Mautino MR, Link CJ, Lin RS, Royer-Joo S, Liang X, Salphati L, Morrissey KM, Mahrus S, McCall B, Pirzkall A, Munn DH, Janik JE, Khleif SN.

J Immunother Cancer. 2018 Jun 20;6(1):61. doi: 10.1186/s40425-018-0351-9.

2.

Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death.

Habtetsion T, Ding ZC, Pi W, Li T, Lu C, Chen T, Xi C, Spartz H, Liu K, Hao Z, Mivechi N, Huo Y, Blazar BR, Munn DH, Zhou G.

Cell Metab. 2018 Aug 7;28(2):228-242.e6. doi: 10.1016/j.cmet.2018.05.012. Epub 2018 Jun 7.

3.

Management of a Complex Case of a Bronchopleural Fistula.

Simmerman EL, Simmerman A, Walsh N, Shafer M, Hao Z, Schroeder C.

Am Surg. 2018 Jan 1;84(1):4-5. No abstract available.

PMID:
29642975
4.

Management of a Complex Case of a Bronchopleural Fistula.

Simmerman EL, Simmerman A, Walsh N, Shafer M, Hao Z, Schroeder C.

Am Surg. 2018 Jan 1;84(1):e4-5. No abstract available.

PMID:
29428009
5.

The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells.

Kuczma MP, Ding ZC, Li T, Habtetsion T, Chen T, Hao Z, Bryan L, Singh N, Kochenderfer JN, Zhou G.

Oncotarget. 2017 Dec 5;8(67):111931-111942. doi: 10.18632/oncotarget.22953. eCollection 2017 Dec 19.

6.

Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells.

Ding ZC, Habtetsion T, Cao Y, Li T, Liu C, Kuczma M, Chen T, Hao Z, Bryan L, Munn DH, Zhou G.

Sci Rep. 2017 Sep 22;7(1):12168. doi: 10.1038/s41598-017-12488-z.

7.

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M; PACIFIC Investigators.

N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8.

8.

Label-free ferrohydrodynamic cell separation of circulating tumor cells.

Zhao W, Cheng R, Jenkins BD, Zhu T, Okonkwo NE, Jones CE, Davis MB, Kavuri SK, Hao Z, Schroeder C, Mao L.

Lab Chip. 2017 Sep 12;17(18):3097-3111. doi: 10.1039/c7lc00680b.

9.

Unusual Contiguous Soft Tissue Spread of Advanced Malignant Mesothelioma Detected by FDG PET/CT.

Zhang Y, Edwards J, Williams H, Hao Z, Khleif S, Pucar D.

Nucl Med Mol Imaging. 2017 Jun;51(2):178-181. doi: 10.1007/s13139-016-0425-x. Epub 2016 Jun 6.

10.

Free Lung Cancer Screening Trends Toward a Twofold Increase in Lung Cancer Prevalence in the Underserved Southeastern United States.

Simmerman EL, Thomson NB 3rd, Dillard TA, Hao Z, Sadek RF, Khleif SN, Schroeder C.

South Med J. 2017 Mar;110(3):188-194. doi: 10.14423/SMJ.0000000000000619.

PMID:
28257543
11.

Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.

Zhen Z, Tang W, Wang M, Zhou S, Wang H, Wu Z, Hao Z, Li Z, Liu L, Xie J.

Nano Lett. 2017 Feb 8;17(2):862-869. doi: 10.1021/acs.nanolett.6b04150. Epub 2017 Jan 4.

PMID:
28027646
12.

X-Ray Induced Photodynamic Therapy: A Combination of Radiotherapy and Photodynamic Therapy.

Wang GD, Nguyen HT, Chen H, Cox PB, Wang L, Nagata K, Hao Z, Wang A, Li Z, Xie J.

Theranostics. 2016 Oct 1;6(13):2295-2305. eCollection 2016.

13.

YM155 inhibits topoisomerase function.

Hong M, Ren MQ, Silva J, Paul A, Wilson WD, Schroeder C, Weinberger P, Janik J, Hao Z.

Anticancer Drugs. 2017 Feb;28(2):142-152. doi: 10.1097/CAD.0000000000000441.

14.

Sunitinib: the antiangiogenic effects and beyond.

Hao Z, Sadek I.

Onco Targets Ther. 2016 Sep 8;9:5495-505. doi: 10.2147/OTT.S112242. eCollection 2016. Review.

15.

Battling regional (stage III) lung cancer: bumpy road of a cancer survivor in the immunotherapy age.

Hao Z, Biddinger P, Schroeder C, Tariq K.

BMJ Case Rep. 2016 Jul 7;2016. pii: bcr2016215304. doi: 10.1136/bcr-2016-215304.

16.

Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.

Zhao J, Xia Y, Kaminski J, Hao Z, Mott F, Campbell J, Sadek R, Kong FM.

PLoS One. 2016 Jun 14;11(6):e0157455. doi: 10.1371/journal.pone.0157455. eCollection 2016.

17.

Volasertib for AML: clinical use and patient consideration.

Hao Z, Kota V.

Onco Targets Ther. 2015 Jul 17;8:1761-71. doi: 10.2147/OTT.S60762. eCollection 2015. Review.

18.

Tumor Lysis Syndrome in Metastatic Colon Cancer Following Treatment with Regorafenib.

Farooqi B, Simmons J, Hao Z.

J Gastrointest Cancer. 2015 Sep;46(3):314-6. doi: 10.1007/s12029-015-9711-6. Review. No abstract available.

PMID:
25859838
19.

Nanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment.

Chen H, Wang GD, Chuang YJ, Zhen Z, Chen X, Biddinger P, Hao Z, Liu F, Shen B, Pan Z, Xie J.

Nano Lett. 2015 Apr 8;15(4):2249-56. doi: 10.1021/nl504044p. Epub 2015 Mar 12.

20.

E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.

Hao Z, Huang S.

Front Biosci (Landmark Ed). 2015 Jan 1;20:474-90. Review.

PMID:
25553462

Supplemental Content

Loading ...
Support Center